Cargando…
Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
PURPOSE: To report the development of type 3 macular neovascularization (MNV) in a patient with pentosan polysulfate sodium (PPS) maculopathy one year after PPS cessation. OBSERVATION: A 72-year-old woman presented for decreased visual acuity in the left eye. Medical history was significant for inte...
Autores principales: | Bousquet, Elodie, Lee, Brian A., Santina, Ahmad, Sadda, SriniVas, Sarraf, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763375/ https://www.ncbi.nlm.nih.gov/pubmed/36561881 http://dx.doi.org/10.1016/j.ajoc.2022.101771 |
Ejemplares similares
-
Maculopathy caused by pentosan polysulfate
por: Rosenberg, Daniel, et al.
Publicado: (2021) -
Maculopathie causée par le polysulfate de pentosan
por: Rosenberg, Daniel, et al.
Publicado: (2021) -
Visual Function in Pentosan Polysulfate Sodium Maculopathy
por: Lyons, Riley J., et al.
Publicado: (2020) -
A case of pentosan polysulfate maculopathy originally diagnosed as stargardt disease
por: Vora, Robin A., et al.
Publicado: (2020) -
Maculopathy Secondary to Pentosan Polysulfate Use: A Single-Center Experience
por: Kalbag, Neil S, et al.
Publicado: (2021)